🇺🇸 FDA
Patent

US 6203778

Particulate radiopaque contrast agent for diagnostic imaging and microvascular characterization

expired A61KA61K49/0428

Quick answer

US patent 6203778 (Particulate radiopaque contrast agent for diagnostic imaging and microvascular characterization) held by The Regents of the University of California expires Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K49/0428